Get the Stockscreener App
13.25
14.46%
-2.24
After Hours:
13.21
-0.04
-0.30%
Mbx Biosciences Inc stock is traded at $13.25, with a volume of 801.08K.
It is down -14.46% in the last 24 hours and up +16.13% over the past month.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
See More
Previous Close:
$15.49
Open:
$15.37
24h Volume:
801.08K
Relative Volume:
2.39
Market Cap:
$442.87M
Revenue:
-
Net Income/Loss:
$-47.20M
P/E Ratio:
-8.4648
EPS:
-1.5653
Net Cash Flow:
$-43.65M
1W Performance:
+1.69%
1M Performance:
+16.13%
6M Performance:
+32.37%
1Y Performance:
+0.00%
1-Day Range:
$13.08
$15.89
1-Week Range:
$12.32
$15.94
52-Week Range:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Name
Mbx Biosciences Inc
Sector
Industry
Phone
(317) 989-3100
Address
11711 N. MERIDIAN STREET, CARMEL
Compare MBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
13.25 | 517.74M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Oppenheimer | Outperform |
| Apr-10-25 | Initiated | Citizens JMP | Mkt Outperform |
| Oct-08-24 | Initiated | Guggenheim | Buy |
| Oct-08-24 | Initiated | JP Morgan | Overweight |
| Oct-08-24 | Initiated | Jefferies | Buy |
| Oct-08-24 | Initiated | Stifel | Buy |
View All
Mbx Biosciences Inc Stock (MBX) Latest News
When is MBX Biosciences Inc. stock expected to show significant growthLow Risk Strategy With Low Risk - jammulinksnews.com
Applying big data sentiment scoring on MBX Biosciences Inc.Oversold Reversal Picks with Buy Zone - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Step-by-Step Trade Signal Implementation - Newser
Tools to assess MBX Biosciences Inc.’s risk profileChart-Based Entry Confirmation for Beginners - Newser
What makes MBX Biosciences Inc. stock price move sharplyFree Daily Chart Pattern Stock Forecast - Newser
How MBX Biosciences Inc. stock performs during market volatilityPre-Market Stock Movement Summary and Review - Newser
Published on: 2025-07-29 13:50:43 - metal.it
Published on: 2025-07-29 06:47:28 - Newser
Sectors Driving Future Growth for MBX Biosciences Inc. StockSwing Candidate List with Trade Cues - Newser
Is MBX Biosciences Inc. Stock a Good Fit for Conservative InvestorsConservative Asset Allocation Risk Analysis - Newser
MBX Biosciences Inc. Breaks Losing Streak — Is the Trend ReversingMarket Entry and Exit Point Tips From Traders - metal.it
MBX Biosciences Inc Inc. (MBX) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
How does MBX Biosciences Inc. generate profit in a changing economyFind market-beating stocks for your portfolio - jammulinksnews.com
What are the latest earnings results for MBX Biosciences Inc.Maximize returns with disciplined investment techniques - jammulinksnews.com
How to manage a losing position in MBX Biosciences Inc.Trend Following Ideas with Volume Confirmation - Newser
How does MBX Biosciences Inc. compare to its industry peersExceptional gains - jammulinksnews.com
New York State Common Retirement Fund Buys Shares of 4,300 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
How strong is MBX Biosciences Inc. company’s balance sheetFree Stock Market Beginners Guide - jammulinksnews.com
What analysts say about MBX Biosciences Inc. stockHigh-profit stock alerts - PrintWeekIndia
What drives MBX Biosciences Inc. stock priceAccelerated wealth building - PrintWeekIndia
Is MBX Biosciences Inc. a good long term investmentExtraordinary market timing - Autocar Professional
Oppenheimer reiterates Outperform rating on MBX Biosciences stock ahead of Phase 2 data - Investing.com Nigeria
MBX Biosciences Inc. Stock Analysis and ForecastBreakthrough financial growth - jammulinksnews.com
Why MBX Biosciences Inc. stock attracts strong analyst attentionSmart Growth Low Risk Picks - Newser
MBX Biosciences (NYSE:MBX) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
MBX Biosciences, Inc. (NYSE:MBX) Receives Average Rating of “Buy” from Analysts - Defense World
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Oppenheimer - Defense World
Mbx Biosciences Inc Stock (MBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):